Ding, W., Shanafelt, T. D., Lesnick, C. E., Erlichman, C., Leis, J. F., Secreto, C., . . . Kay, N. E. (2013). Akt Inhibitor MK2206 Selectively Targets CLL B-cell Receptor Induced Cytokines, Mobilizes Lymphocytes and Synergizes with Bendamustine to Induce CLL Apoptosis.
Chicago Stili AlıntıDing, Wei, et al. Akt Inhibitor MK2206 Selectively Targets CLL B-cell Receptor Induced Cytokines, Mobilizes Lymphocytes and Synergizes With Bendamustine to Induce CLL Apoptosis. 2013.
MLA AlıntıDing, Wei, et al. Akt Inhibitor MK2206 Selectively Targets CLL B-cell Receptor Induced Cytokines, Mobilizes Lymphocytes and Synergizes With Bendamustine to Induce CLL Apoptosis. 2013.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..